Pfizer has launched a late-stage clinical trial to test a vaccine that could protect against Lymedisease.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer just started a late-stage clinical trial of a Lyme disease vaccineIf the trial succeeds, the vaccine could be the first human immunization for Lyme disease in the U.S. in two decades.
Read more »
Monkeypox is not 'only circulating in countries distributing Pfizer-BioNTech vaccine'Multiple social media posts shared hundreds of times claim that the latest outbreak of monkeypox is only occurring in countries that have administered Pfizer-BioNTech's Covid-19 vaccine. The posts go on to claim the World Health Organization (WHO) 'has not received a single report' of monkeypox from countries not administering the Pfizer-BioNTech vaccine. Medical experts, however, told the AFP there is no evidence linking the virus, which has existed for decades, to the Covid vaccine. As of August 9, 2022, most countries that were administering the Pfizer-BioNTech vaccine had not recorded cases of monkeypox. Conversely, several countries -- including India, Russia and Venezuela -- where the Pfizer-BioNTech vaccine has not been distributed had reported monkeypox cases.
Read more »
Vaccine Targeting Fast-Spreading Omicron Subvariants Could Be Ready For Fall As Pfizer, BioNTech Announce TrialsPfizer and BioNTech will begin trials of their updated mRNA Covid-19 vaccine designed to protect against the newer BA.4 and BA.5 sub-variants of the coronavirus later this month.
Read more »
Vaccine Targeting Fast-Spreading Omicron Subvariants Could Be Ready For Fall As Pfizer, BioNTech Announce TrialsPfizer and BioNTech will begin trials of their updated mRNA Covid-19 vaccine designed to protect against the newer BA.4 and BA.5 sub-variants of the coronavirus later this month.
Read more »
Pfizer to buy South SF-based Global Blood Therapeutics in $5.4B dealPfizer will spend about $5.4 billion to buy Global Blood Therapeutics as the pharmaceutical giant continues to invest some of the cash influx reaped during the COVID-19 pandemic.
Read more »
Pfizer Agrees to $5.4 Billion Deal for Global Blood TherapeuticsPfizer has agreed to buy Global Blood Therapeutics for $5.4 billion, a deal that will give the big drugmaker a foothold in the treatment of sickle-cell disease.
Read more »